Renal Replacement in Acute Kidney Injury During Moderate Metabolic Disarray
Renal Replacement in Acute Kidney Injury During Moderate Metabolic Disarray
批准号:
8320534
负责人:
FRANCIS PERRY WILSON
金额:
$7.23万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-08-05 至 2013-07-14
关键词:
AcidosisAcute Renal Failure with Renal Papillary NecrosisAffectAnimal ModelAzotemiaBasic ScienceBiochemicalBlood - brain barrier anatomyBlood Urea NitrogenCessation of lifeClinicalClinical ResearchComplicationCritical IllnessDataData AnalysesDevelopmentDialysis procedureDiseaseDistantDoseEarly treatmentElectrolytesExcisionExclusionFutureHemodialysisHospital MortalityHospitalsInflammatory ResponseInjuryK-Series Research Career ProgramsKidneyLaboratoriesLearningLeukocyte TraffickingLifeManuscriptsMaster of ScienceMeasurableMeasuresMediatingMetabolicMethodsMetricMinorModelingObservational StudyOliguriaOutcomePatientsProcessPublicationsRecoveryRenal Replacement TherapyResearchResearch DesignResearch MethodologyResearch PriorityResearch Project GrantsRiskSerumSeveritiesSyndromeTimeToxinUp-RegulationVariantWorkbaseclinical epidemiologyclinical practicecohortdesignepidemiology studyexperiencehyperkalemiaimprovedmortalityprophylacticresponsesolute
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Acute kidney injury (AKI) is a common complication of critical illness, with even minor degrees of AKI conferring an independent risk of death (1, 2). No therapy currently exists that has been definitively demonstrated to improve outcomes in AKI, although renal replacement therapy (RRT) is frequently necessary as a life-sustaining measure once oliguria, severe azotemia, or significant electrolyte abnormalities develop. Defining the indications for and timing of RRT in the setting of AKI is a priority research topic identified by the Acute Kidney Injury Network. Prior studies examining timing of RRT in acute kidney injury typically have been limited to patients with AKI who received RRT, rendering them unable to evaluate the indications for this therapy, and the impact of therapy versus no therapy (3, 4). Reframing the questions regarding RRT in the setting of AKI, we have designed a study to examine the impact on mortality of initiating dialysis therapy during a period of moderate metabolic disarray, defined as the period of time after acute kidney injury, when laboratory abnormalities are detectable, but before absolute indications for dialysis have arisen. We take advantage of the variations in clinical practice during early AKI prior to when RRT is required as a life-sustaining measure to design an observational study that will permit us to accomplish the following specific aims: Aim 1: Develop a metric defining moderate metabolic disarray and assess the association of duration and severity of moderate metabolic disarray prior to initiation of RRT with the rate of mortality. We will create a score based on a multiple regression model of likelihood to receive dialysis based on a variety of factors, and use that likelihood to define degree of disarray. We will then assess the impact of duration and severity of moderate disarray with these methods (censored at initiation of dialysis or development of severe disarray) on predicting in-hospital mortality. Aim 2: Assess the impact of renal replacement therapy (RRT) initiated during moderate metabolic disarray on in-hospital mortality in a cohort of critically ill patients with AKI The proposed research project will be in the context of the applicant working towards a Masters of Science in Clinical Epidemiology, whereby didactic learning in the classroom, focusing on fundamentals of epidemiology, study design, and statistical and analytic methods of research will enhance and guide the research process of the applicant. The long-term objectives of the applicant for this project are to collect and analyze the data, prepare manuscripts for publication, and build upon the data as part of a future application for a K award.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
Vancomycin levels are frequently subtherapeutic during continuous venovenous hemodialysis (CVVHD).
在连续的静脉血液透析(CVVHD)期间,万古霉素水平经常是亚治疗。
DOI:
10.5414/cn106993
发表时间:
2012-04
期刊:
Clinical nephrology
影响因子:
1.1
作者:
[Wilson FP, Berns JS]
通讯作者:
Berns JS
DOI:
10.1053/j.ackd.2013.07.001
发表时间:
2014-01
期刊:
Advances in chronic kidney disease
影响因子:
2.9
作者:
[Wilson FP, Berns JS]
通讯作者:
Berns JS
Sundays and mortality in patients with AKI.
AKI 患者的周日和死亡率。
DOI:
10.2215/cjn.03540413
发表时间:
2013
期刊:
Clinical journal of the American Society of Nephrology : CJASN
影响因子:
--
作者:
[Wilson,FPerry, Yang,Wei, Schrauben,Sarah, Machado,Carlos, Lin,JennieJ, Feldman,HaroldI]
通讯作者:
Feldman,HaroldI
Personalized Recommendations for Acute Kidney Injury (AKI) Care Using a Kidney Action Team: A Randomized Trial
-
批准号:10211505
-
项目类别:
-
资助金额:$38.47万
-
财政年份:2021
-
负责人:FRANCIS PERRY WILSON
-
依托单位:
Personalized Recommendations for Acute Kidney Injury (AKI) Care Using a Kidney Action Team: A Randomized Trial
-
批准号:10608966
-
项目类别:
-
资助金额:$39.27万
-
财政年份:2021
-
负责人:FRANCIS PERRY WILSON
-
依托单位:
Personalized Recommendations for Acute Kidney Injury (AKI) Care Using a Kidney Action Team: A Randomized Trial
-
批准号:10385755
-
项目类别:
-
资助金额:$39.33万
-
财政年份:2021
-
负责人:FRANCIS PERRY WILSON
-
依托单位:
Optimizing Electronic Alerts for Acute Kidney Injury
-
批准号:10337243
-
项目类别:
-
资助金额:$59.76万
-
财政年份:2018
-
负责人:FRANCIS PERRY WILSON
-
依托单位:
Mediators & prognostic value of muscle mass & function in chronic kidney disease
-
批准号:8700394
-
项目类别:
-
资助金额:$2.71万
-
财政年份:2013
-
负责人:FRANCIS PERRY WILSON
-
依托单位:
Mediators & prognostic value of muscle mass & function in chronic kidney disease
-
批准号:8973660
-
项目类别:
-
资助金额:$15.5万
-
财政年份:2013
-
负责人:FRANCIS PERRY WILSON
-
依托单位:
Mediators & prognostic value of muscle mass & function in chronic kidney disease
-
批准号:8853857
-
项目类别:
-
资助金额:$17.93万
-
财政年份:2013
-
负责人:FRANCIS PERRY WILSON
-
依托单位:
Mediators & prognostic value of muscle mass & function in chronic kidney disease
-
批准号:9267351
-
项目类别:
-
资助金额:$19.34万
-
财政年份:2013
-
负责人:FRANCIS PERRY WILSON
-
依托单位:
Mediators & prognostic value of muscle mass & function in chronic kidney disease
-
批准号:8581453
-
项目类别:
-
资助金额:$18.21万
-
财政年份:2013
-
负责人:FRANCIS PERRY WILSON
-
依托单位:
Mortality Effect of Renal Replacement Therapy for Acute Kidney Injury Initiated D
-
批准号:8202629
-
项目类别:
-
资助金额:$7.28万
-
财政年份:2011
-
负责人:FRANCIS PERRY WILSON
-
依托单位: